Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation.
Fiser
S M
SM
Department of Thoracic and Cardiovascular Surgery, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
Cope
J T
JT
Kron
I L
IL
Kaza
A K
AK
Long
S M
SM
Kern
J A
JA
Tribble
C G
CG
Lowson
S M
SM
D000280:Administration, Inhalation; D000336:Aerosols; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D011464:Epoprostenol / Q000008:administration & dosage*; D006801:Humans; D008168:Lung / Q000098:blood supply*; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000008:administration & dosage*; D011651:Pulmonary Artery / Q000503:physiopathology; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014665:Vasodilator Agents / Q000008:administration & dosage*
D000336:Aerosols; D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol